OSCR

NADPH oxidase 3 inhibition preserves hearing in mice after stereotactic radiosurgery.

Overview

Authors: Dimitrios Daskalou1,2, Francis Rousset1, Stéphanie Sgroi1, Lucie Oberhauser1, Jean-Philippe Thiran3,4, Constantin Tuleasca5, Ileana O. Jelescu4, Marc Levivier5,6, Pascal Senn1,2
  1. The Inner Ear and Olfaction Lab, University of Geneva, Faculty of Medicine, 1211 Geneva, Switzerland
  2. Service of Otorhinolaryngology-Head and Neck Surgery, Department of Clinical Neurosciences, Geneva University Hospitals, 1205 Geneva, Switzerland
  3. Signal Processing Laboratory 5, École Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland
  4. Department of Radiology, Lausanne University Hospital (CHUV), 1011 Lausanne, Switzerland
  5. Neurosurgery Service and Gamma Knife Center, Lausanne University Hospital (CHUV), Rue du Bugnon 44-46, BH-08, 1011 Lausanne, Switzerland
  6. Hôpital de La Tour, Centre NeuroKnife, Av. J.-D.-Maillard 3, 1217 Meyrin, Switzerland
Journal: Molecular therapy. Nucleic acids, volume 37, issue 3, article 103036
Dates: received 29 December 2025; accepted 21 July 2026; published online 22 July 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.1016/j.omtn.2026.103036 · PMID 42621021 · PMCID PMC13487719 · OpenAlex W7170038219
Open access: gold, a free copy (OpenAlex)
Status: code on request (how the code is found and verified)
Categories: mouse (organism), other condition (population)
Methods: Spectral & time-frequency, Statistics, fMRI & imaging
Keywords: MT: oligonucleotides: therapies and applications, radiation-induced hearing loss, stereotactic radiosurgery, NADPH oxidase 3 (NOX3), cochlear injury, small interfering RNA, inner ear drug delivery, oxidative stress, otoprotection, vestibular schwannoma
Topic: Neutrophil, Myeloperoxidase and Oxidative Mechanisms (Immunology, Immunology and Microbiology), according to OpenAlex
Citations: not cited yet (Europe PMC); 79 references in the paper

Abstract

Stereotactic radiosurgery (SRS) is a standard treatment for vestibular schwannoma but is associated with a substantial risk of progressive and irreversible hearing loss. NADPH oxidase 3 (NOX3), an enzyme predominantly expressed in the inner ear, has been identified as a key source of oxidative stress underlying cochlear injury. Using a mouse model of SRS-induced hearing loss, we found that genetic deletion of Nox3 preserved auditory function and protected cochlear structures, including hair cells, synaptic ribbons, and spiral ganglion neurons. Complementary experiments using local delivery of a small interfering RNA directed against Nox3 confirmed that transient inhibition markedly reduced hearing loss and tissue damage compared with scrambled controls. In addition, Nox3 inhibition attenuated radiation-induced lipid peroxidation and macrophage infiltration within the cochlea. These findings identify NOX3-derived oxidative stress as an important upstream mediator of SRS-induced ototoxicity and demonstrate that its inhibition confers significant functional and structural protection. Given the predictable timing of SRS in clinical settings, a NOX3-targeted intervention may offer a feasible and selective strategy to prevent hearing loss as an adjunct to tumor-directed treatment.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper says that its authors' code is available on request: it was not published with the paper, so there is nothing to verify.

The paper's code and data availability statement is in the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none (its code is available on request), so it has no map.

Data

No dataset and no data link were found in the paper.

Data and code availability

The data supporting the findings of this study are available from the corresponding author upon reasonable request.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 2, 28 September 2026

  • Authors: added Dimitrios Daskalou (0000-0003-3618-9776); Jean-Philippe Thiran (0000-0003-2938-9657); Constantin Tuleasca (0000-0001-6776-1486); removed Dimitrios Daskalou; Jean-Philippe Thiran; Constantin Tuleasca

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 9 authors, 10 keywords, 2 funders, 78 references.

Cite

This paper

Daskalou, D., Rousset, F., Sgroi, S., Oberhauser, L., Thiran, J.-P., Tuleasca, C., Jelescu, I. O., Levivier, M., & Senn, P. (2026). NADPH oxidase 3 inhibition preserves hearing in mice after stereotactic radiosurgery. Molecular therapy. Nucleic acids, 37(3), 103036. https://doi.org/10.1016/j.omtn.2026.103036

BibTeX

@article{daskalou2026nadph,
author = {Daskalou, Dimitrios and Rousset, Francis and Sgroi, Stéphanie and Oberhauser, Lucie and Thiran, Jean-Philippe and Tuleasca, Constantin and Jelescu, Ileana O. and Levivier, Marc and Senn, Pascal},
title = {{NADPH oxidase 3 inhibition preserves hearing in mice after stereotactic radiosurgery}},
journal = {Molecular therapy. Nucleic acids},
year = {2026},
month = jul,
volume = {37},
number = {3},
pages = {103036},
publisher = {American Society of Gene \& Cell Therapy},
issn = {2162-2531},
doi = {10.1016/j.omtn.2026.103036},
url = {https://doi.org/10.1016/j.omtn.2026.103036},
pmid = {42621021},
pmcid = {PMC13487719}
}

RIS

TY - JOUR
AU - Daskalou, Dimitrios
AU - Rousset, Francis
AU - Sgroi, Stéphanie
AU - Oberhauser, Lucie
AU - Thiran, Jean-Philippe
AU - Tuleasca, Constantin
AU - Jelescu, Ileana O.
AU - Levivier, Marc
AU - Senn, Pascal
TI - NADPH oxidase 3 inhibition preserves hearing in mice after stereotactic radiosurgery
T2 - Molecular therapy. Nucleic acids
J2 - Mol Ther Nucleic Acids
PY - 2026
DA - 2026/07/22
VL - 37
IS - 3
SP - 103036
SN - 2162-2531
PB - American Society of Gene & Cell Therapy
DO - 10.1016/j.omtn.2026.103036
UR - https://doi.org/10.1016/j.omtn.2026.103036
LA - en
ER -

CSL-JSON

{
"id": "10.1016/j.omtn.2026.103036",
"type": "article-journal",
"title": "NADPH oxidase 3 inhibition preserves hearing in mice after stereotactic radiosurgery",
"container-title": "Molecular therapy. Nucleic acids",
"author": [
{
"family": "Daskalou",
"given": "Dimitrios"
},
{
"family": "Rousset",
"given": "Francis"
},
{
"family": "Sgroi",
"given": "Stéphanie"
},
{
"family": "Oberhauser",
"given": "Lucie"
},
{
"family": "Thiran",
"given": "Jean-Philippe"
},
{
"family": "Tuleasca",
"given": "Constantin"
},
{
"family": "Jelescu",
"given": "Ileana O."
},
{
"family": "Levivier",
"given": "Marc"
},
{
"family": "Senn",
"given": "Pascal"
}
],
"container-title-short": "Mol Ther Nucleic Acids",
"volume": "37",
"issue": "3",
"page": "103036",
"DOI": "10.1016/j.omtn.2026.103036",
"PMID": "42621021",
"PMCID": "PMC13487719",
"ISSN": "2162-2531",
"publisher": "American Society of Gene & Cell Therapy",
"URL": "https://doi.org/10.1016/j.omtn.2026.103036",
"language": "en",
"issued": {
"date-parts": [
[
2026,
7,
22
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.3390/ijms24043320 [code]
Conditional Ablation of Glucocorticoid and Mineralocorticoid Receptors from Cochlear Supporting Cells Reveals Their Differential Roles for Hearing Sensitivity and Dynamics of Recovery from Noise-Induced Hearing Loss.
Journal: International journal of molecular sciences
In common: other condition, mouse, 3 references
[2] doi:10.1038/s41598-024-52410-y [code]
Dynamic functional changes upon thalamotomy in essential tremor depend on baseline brain morphometry.
Journal: Scientific reports
In common: other condition, author Constantin Tuleasca
[3] doi:10.1016/j.nicl.2022.103283 [code]
Exploring the heterogeneous morphometric data in essential tremor with probabilistic modelling.
Journal: NeuroImage. Clinical
In common: other condition, author Constantin Tuleasca
[4] doi:10.1162/netn_a_00253 [code]
Morphometric features of drug-resistant essential tremor and recovery after stereotactic radiosurgical thalamotomy.
Journal: Network neuroscience (Cambridge, Mass.)
In common: other condition, author Constantin Tuleasca
[5] doi:10.3389/fnagi.2022.873605 [code]
Graph Theoretical Analysis of Structural Covariance Reveals the Relevance of Visuospatial and Attentional Areas in Essential Tremor Recovery After Stereotactic Radiosurgical Thalamotomy.
Journal: Frontiers in aging neuroscience
In common: other condition, author Constantin Tuleasca
[6] doi:10.1002/hbm.70367 [code]
Deep Learning for fODF Estimation in Infant Brains: Model Comparison, Ground-Truth Impact, and Domain Shift Mitigation.
Journal: Human brain mapping
In common: author Jean-Philippe Thiran
[7] doi:10.1002/mrm.29991 [code]
Pore size estimation in axon-mimicking microfibers with diffusion-relaxation MRI.
Journal: Magnetic resonance in medicine
In common: author Jean-Philippe Thiran
[8] doi:10.3389/fneur.2022.939640
Toward individualized medicine in stroke-The TiMeS project: Protocol of longitudinal, multi-modal, multi-domain study in stroke.
Journal: Frontiers in neurology
In common: author Jean-Philippe Thiran
[9] doi:10.1016/j.nicl.2022.103205 [code]
Cortical lesions, central vein sign, and paramagnetic rim lesions in multiple sclerosis: Emerging machine learning techniques and future avenues.
Journal: NeuroImage. Clinical
In common: author Jean-Philippe Thiran
[10] doi:10.1002/nbm.4730 [code]
Multiple sclerosis cortical lesion detection with deep learning at ultra-high-field MRI.
Journal: NMR in biomedicine
In common: author Jean-Philippe Thiran

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.